# HEY2

## Overview
HEY2 is a gene that encodes the hes related family bHLH transcription factor with YRPW motif 2, a member of the basic helix-loop-helix (bHLH) transcription factor family. This protein plays a pivotal role in the regulation of gene expression, particularly during cardiovascular development, by functioning as a transcriptional repressor. It is involved in the NOTCH signaling pathway, which is crucial for cell fate decisions and tissue homeostasis (Katoh2007Integrative; Heisig2012Target). The HEY2 protein is characterized by its bHLH domain, which facilitates DNA binding and dimerization, and an Orange domain that modulates dimerization affinity. It also contains a conserved C-terminal YRPW motif (Fischer2003Hey; Heisig2012Target). HEY2 is essential for normal heart development, influencing the differentiation of cardiomyocytes and ventricular formation, and is implicated in various cardiac conditions, including congenital heart defects and Brugada syndrome (Anderson2018NKX25; Veerman2017The).

## Structure
The HEY2 protein is a member of the basic helix-loop-helix (bHLH) transcription factor family, characterized by a bHLH domain that facilitates DNA binding and dimerization. This domain is crucial for its function as a transcriptional repressor, allowing HEY2 to bind to E-box motifs in DNA, with a preference for the sequence CACGTG (Fischer2003Hey; Heisig2012Target). The protein also contains an Orange domain, which modulates dimerization affinity, and a conserved C-terminal YRPW motif, although the specific interaction partners of this motif are not well-defined (Fischer2003Hey; Heisig2012Target).

HEY2 can form both homo- and heterodimers with other bHLH proteins, which may influence its DNA-binding specificity and repressive functions (Fischer2003Hey). The protein interacts with corepressors such as mSin3 and N-CoR, and it can recruit histone deacetylase SIRT1, enhancing its transcriptional repression capabilities (Takata2003Human). Despite these functional insights, specific details on the primary, secondary, tertiary, or quaternary structure of HEY2 are not provided in the available literature. The protein's activity and interactions may be influenced by post-translational modifications and splice variants, although these aspects are not extensively detailed in the context provided.

## Function
HEY2 is a basic helix-loop-helix (bHLH) transcription factor that plays a significant role in the regulation of gene expression during development, particularly in cardiovascular development. It functions primarily as a transcriptional repressor, modulating gene expression by binding to DNA at specific sites, often near transcriptional start sites of target genes (Heisig2012Target). HEY2 is a critical effector in the NOTCH signaling pathway, which is essential for various cell fate decisions and tissue homeostasis (Katoh2007Integrative; Heisig2012Target).

In the context of heart development, HEY2 is involved in the differentiation of cardiomyocytes and is crucial for normal ventricular development. It suppresses atrial gene expression and is more highly expressed in the compact myocardium (Anderson2018NKX25). Knockout studies in mice have shown that HEY2 is essential for proper ventricular septal and valve formation, with mutations leading to severe defects and neonatal death (Anderson2018NKX25; Fischer2004The).

HEY2 also interacts with other proteins, such as SIRT1, to mediate transcriptional repression through chromatin modification, further influencing gene expression and cellular differentiation processes (Takata2003Human).

## Clinical Significance
Mutations and altered expression of the HEY2 gene have been implicated in several cardiac conditions. HEY2 is crucial for heart development, and mutations in this gene are associated with congenital heart defects such as ventricular septal defects (VSD) and atrioventricular septal defects (AVSD). In a study, three nonsynonymous mutations in the bHLH domain of HEY2 were identified in patients with AVSD, suggesting a role in ventricular septation (ReamonBuettner2005HEY2). 

HEY2 is also linked to Brugada syndrome (BrS), an inherited cardiac rhythm disorder. Genetic variations near the HEY2 gene are associated with BrS, and the risk allele is linked to higher HEY2 expression, affecting cardiac ion channel gene expression and contributing to electrical heterogeneity in the heart (Veerman2017The). HEY2 influences the expression of ion channel subunits such as KCNIP2, impacting action potential duration and contributing to the pathophysiology of BrS (Veerman2017The).

In mice, disruption of the CHF1/Hey2 gene results in VSDs and cardiomyopathy, highlighting its role in myocardial contractility and cardiac development (Sakata2002Ventricular). These findings underscore the clinical significance of HEY2 in cardiac health and disease.

## Interactions
HEY2, a basic helix-loop-helix (bHLH) transcription factor, participates in several physical interactions with other proteins and nucleic acids. It is known to interact with the human SIRT1 protein, a relationship demonstrated through co-immunoprecipitation and in vitro pulldown assays. These studies suggest that the bHLH domain of HEY2 is crucial for its interaction with SIRT1, which is involved in transcriptional repression (Takata2003Human). HEY2 also interacts with the mSin3 complex, which includes histone deacetylase HDAC1, contributing to its role in transcriptional repression through chromatin modification (Takata2003Human).

HEY2 binds to DNA at E-box motifs, such as CACGTG, and is involved in repressing target gene promoters. This binding is often near transcription start sites and is associated with active or poised promoters marked by H3K4me3 histone marks (Heisig2012Target). HEY2's interaction with DNA is highly specific, as shown by chromatin immunoprecipitation (ChIP) experiments, which identified numerous binding sites across the genome (Heisig2012Target). These interactions underscore HEY2's role as a transcriptional repressor in various cellular processes, including those regulated by the NOTCH signaling pathway (Heisig2012Target).


## References


[1. (Takata2003Human) Takehiko Takata and Fuyuki Ishikawa. Human sir2-related protein sirt1 associates with the bhlh repressors hes1 and hey2 and is involved in hes1- and hey2-mediated transcriptional repression. Biochemical and Biophysical Research Communications, 301(1):250–257, January 2003. URL: http://dx.doi.org/10.1016/s0006-291x(02)03020-6, doi:10.1016/s0006-291x(02)03020-6. This article has 112 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/s0006-291x(02)03020-6)

[2. (Fischer2003Hey) A Fischer. Hey genes in cardiovascular development. Trends in Cardiovascular Medicine, 13(6):221–226, August 2003. URL: http://dx.doi.org/10.1016/S1050-1738(03)00082-3, doi:10.1016/s1050-1738(03)00082-3. This article has 95 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/S1050-1738(03)00082-3)

[3. (Anderson2018NKX25) David J. Anderson, David I. Kaplan, Katrina M. Bell, Katerina Koutsis, John M. Haynes, Richard J. Mills, Dean G. Phelan, Elizabeth L. Qian, Ana Rita Leitoguinho, Deevina Arasaratnam, Tanya Labonne, Elizabeth S. Ng, Richard P. Davis, Simona Casini, Robert Passier, James E. Hudson, Enzo R. Porrello, Mauro W. Costa, Arash Rafii, Clare L. Curl, Lea M. Delbridge, Richard P. Harvey, Alicia Oshlack, Michael M. Cheung, Christine L. Mummery, Stephen Petrou, Andrew G. Elefanty, Edouard G. Stanley, and David A. Elliott. Nkx2-5 regulates human cardiomyogenesis via a hey2 dependent transcriptional network. Nature Communications, April 2018. URL: http://dx.doi.org/10.1038/s41467-018-03714-x, doi:10.1038/s41467-018-03714-x. This article has 80 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41467-018-03714-x)

[4. (Sakata2002Ventricular) Yasuhiko Sakata, Caramai N. Kamei, Hironori Nakagami, Roderick Bronson, James K. Liao, and Michael T. Chin. Ventricular septal defect and cardiomyopathy in mice lacking the transcription factor chf1/hey2. Proceedings of the National Academy of Sciences, 99(25):16197–16202, November 2002. URL: http://dx.doi.org/10.1073/pnas.252648999, doi:10.1073/pnas.252648999. This article has 143 citations.](https://doi.org/10.1073/pnas.252648999)

[5. (ReamonBuettner2005HEY2) Stella Marie Reamon-Buettner and Juergen Borlak. Hey2 mutations in malformed hearts. Human Mutation, 27(1):118–118, 2005. URL: http://dx.doi.org/10.1002/humu.9390, doi:10.1002/humu.9390. This article has 46 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1002/humu.9390)

[6. (Veerman2017The) Christiaan C. Veerman, Svitlana Podliesna, Rafik Tadros, Elisabeth M. Lodder, Isabella Mengarelli, Berend de Jonge, Leander Beekman, Julien Barc, Ronald Wilders, Arthur A.M. Wilde, Bastiaan J. Boukens, Ruben Coronel, Arie O. Verkerk, Carol Ann Remme, and Connie R. Bezzina. The brugada syndrome susceptibility gene hey2 modulates cardiac transmural ion channel patterning and electrical heterogeneity. Circulation Research, 121(5):537–548, August 2017. URL: http://dx.doi.org/10.1161/CIRCRESAHA.117.310959, doi:10.1161/circresaha.117.310959. This article has 75 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1161/CIRCRESAHA.117.310959)

[7. (Heisig2012Target) Julia Heisig, David Weber, Eva Englberger, Anja Winkler, Susanne Kneitz, Wing-Kin Sung, Elmar Wolf, Martin Eilers, Chia-Lin Wei, and Manfred Gessler. Target gene analysis by microarrays and chromatin immunoprecipitation identifies hey proteins as highly redundant bhlh repressors. PLoS Genetics, 8(5):e1002728, May 2012. URL: http://dx.doi.org/10.1371/journal.pgen.1002728, doi:10.1371/journal.pgen.1002728. This article has 61 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1371/journal.pgen.1002728)

[8. (Katoh2007Integrative) Masuko Katoh and Masaru Katoh. Integrative genomic analyses on hes/hey family: notch-independent hes1, hes3 transcription in undifferentiated es cells, and notch-dependent hes1, hes5, hey1, hey2, heyl transcription in fetal tissues, adult tissues, or cancer. International Journal of Oncology, August 2007. URL: http://dx.doi.org/10.3892/ijo.31.2.461, doi:10.3892/ijo.31.2.461. This article has 10 citations and is from a peer-reviewed journal.](https://doi.org/10.3892/ijo.31.2.461)

[9. (Fischer2004The) Andreas Fischer, Nina Schumacher, Manfred Maier, Michael Sendtner, and Manfred Gessler. The notch target genes hey1 and hey2 are required for embryonic vascular development. Genes &amp; Development, 18(8):901–911, April 2004. URL: http://dx.doi.org/10.1101/gad.291004, doi:10.1101/gad.291004. This article has 540 citations.](https://doi.org/10.1101/gad.291004)